Tele-education to manage diabetes complications during Ramadan
Effectiveness of a Ramadan-focused Structured Diabetes Tele-education in Reducing Diabetes Complications During Ramadan Fasting in South East Asia
This study tests a tele-education program to help adults with type 2 diabetes manage their condition while fasting during Ramadan and see if it reduces complications.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 21 Years to 100 Years |
| Sex | All |
| Sponsor | Sengkang General Hospital Academic / other |
| Locations | 1 site (Singapore) |
| Trial ID | NCT06043843 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a structured tele-education program focused on diabetes management for Muslims fasting during Ramadan. It aims to reduce complications associated with diabetes by providing tailored education and medication adjustments through remote monitoring. The study will recruit 300 adults with type 2 diabetes who are able to fast for at least 15 days during Ramadan and will be randomized into intervention and control groups. The intervention includes guidance on managing diabetes effectively during fasting periods.
Who should consider this trial
Good fit: Ideal candidates are adults aged 21 and older with type 2 diabetes who can fast for at least 15 days during Ramadan.
Not a fit: Patients with severe diabetes complications, such as end-stage renal failure, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce diabetes-related complications for fasting Muslims during Ramadan.
How similar studies have performed: Other studies have shown promising results with tele-education approaches in managing chronic conditions, suggesting potential success for this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults with diabetes planning to fast in Ramadan, 1. Adults with type 2 diabetes aged at least 21 years old, 2. Able to fast at least 15 days in Ramadan based on experience of fasting in previous year's Ramadan, 3. Underlying type 2 diabetes treated with basal insulin and one or more doses of prandial insulin, or at least twice-daily premixed insulin 4. Performed laboratory tests as per standard care - glycated haemoglobin (HbA1c), serum Low Density Lipoprotein- cholesterol, serum triglycerides, serum High Density Lipoprotein- cholesterol, serum Total cholesterol and serum creatinine 5. Ability to give informed consent, 6. Ability to perform self-monitoring blood glucose 7. Have had diabetes-related clinic visits or hospitalization in the past 10 months. 8. Have the capacity for video conferencing (internet connection with mobile phone or computer) Exclusion Criteria: 1. Severe diabetes complications including end-stage renal failure 2. Severe hypoglycemia and hyperglycemic crises within the last 3 months 3. Advanced comorbidities negating the ability to fast 4. Pregnancy 5. Patients on oral medications alone or oral medications plus basal insulin alone 6. Patients on sulfonylureas
Where this trial is running
Singapore
- Sengkang General Hospital — Singapore, Singapore (Recruiting)
Study contacts
- Principal investigator: Sueziani B Zainudin — Sengkang General Hospital
- Study coordinator: Baskar Rajamanickam
- Email: research@skh.com.sg
- Phone: 69304463
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.